Cancer Biomarkers: The Urokinase Plasminogen Activator System: Molecular Mechanisms and Clinical Relevance [Kõva köide]

Edited by , Edited by , Edited by , Edited by , Edited by
  • Formaat: Hardback, 460 pages, kõrgus x laius: 240x170 mm, 50 Illustrations, black and white
  • Ilmumisaeg: 15-Jan-2020
  • Kirjastus: de Gruyter
  • ISBN-10: 3110283395
  • ISBN-13: 9783110283396
Teised raamatud teemal:
  • Kõva köide
  • Hind: 143,45 EUR
  • Lisa soovinimekirja
  • Raamatut on võimalik tellida. Raamatu kohalejõudmiseks kirjastusest kulub orienteeruvalt 2-4 nädalat.
  • Lisa ostukorvi
  • Kogus:
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Raamatukogudele
    • De Gruyter e-raamatud
Cancer Biomarkers: The Urokinase Plasminogen Activator System: Molecular Mechanisms and Clinical Relevance
  • Formaat: Hardback, 460 pages, kõrgus x laius: 240x170 mm, 50 Illustrations, black and white
  • Ilmumisaeg: 15-Jan-2020
  • Kirjastus: de Gruyter
  • ISBN-10: 3110283395
  • ISBN-13: 9783110283396
Teised raamatud teemal:

The serine protease urokinase-type plasminogen activator, its inhibitor and its receptor are considered the most valuable prognostic cancer biomarkers relevant to predict the clinical course of cancer patients and their response to cancer therapy. They are also among the few biomarkers that have been evaluated successfully in clinical studies for their clinical utility, for the most part in early breast cancer. This work provides an overview of the molecular mechanisms and clinical outlook of this important proteolytic system.